A National Registry For Pulmonary Alveolar Proteinosis
Sponsor: Children's Hospital Medical Center, Cincinnati
A observational or N/A phase clinical study on Pulmonary Alveolar Proteinosis, this trial is actively recruiting participants. The trial is conducted by Children's Hospital Medical Center, Cincinnati and has accumulated 18 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
18 versions recorded-
Feb 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
-
Jun 2023 — Feb 2024 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Mar 2023 — Jun 2023 [monthly]
Recruiting
-
Apr 2022 — Mar 2023 [monthly]
Recruiting
-
Dec 2021 — Apr 2022 [monthly]
Recruiting
-
Feb 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2020 — Nov 2020 [monthly]
Recruiting
-
Mar 2019 — Feb 2020 [monthly]
Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital Medical Center, Cincinnati
- National Center for Advancing Translational Sciences (NCATS)
- National Heart, Lung, and Blood Institute (NHLBI)
- Rare Diseases Clinical Research Network
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Cincinnati, United States